4% Tetrasodium EDTA to Prevent Central Venous Access Device-Associated Complications: A Randomized Clinical Trial.
- Journal:
- JAMA: The Journal of the American Medical Association
- Published:
- Affiliations:
- 7
- Authors:
- 12
| Institutions | Authors | Share |
|---|---|---|
| The University of British Columbia (UBC), Canada | 0.48 | |
| Simon Fraser University (SFU), Canada | 0.15 | |
| Centre for Advancing Health Outcomes, Canada | 0.13 | |
| Fraser Health, Canada | 0.10 | |
| University of Manitoba, Canada | 0.08 | |
| Royal Columbian Hospital, Canada | 0.06 |